China’s NMPA has issued the Guiding Opinions on the Standardised Development of Modern Pharmaceutical Logistics (No. 7/2026), outlining a unified framework to advance a fully digital, traceable, and compliance‑driven pharmaceutical supply chain. The document strengthens expectations on end‑to‑end traceability, integrated ERP/WMS/transport systems, and elevated warehouse and cold‑chain standards, alongside enhanced data‑integrity and cybersecurity obligations. These measures signal a clear regulatory shift toward higher operational discipline for logistics operators and MAHs, with notable implications for infrastructure and compliance systems.